Difference between revisions of "MR Coordinating Committee"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
:Chairs: Mark Rosen, MD, PhD (Co-Chair), Gudrun Zahlmann, PhD (Co-chair), Cathy Elsinger, PhD (Vice-chair) | :Chairs: Mark Rosen, MD, PhD (Co-Chair), Gudrun Zahlmann, PhD (Co-chair), Cathy Elsinger, PhD (Vice-chair) | ||
| − | :Secretary: Susan | + | :Secretary: Susan Stanfa (RSNA Staff) |
:[[Media:QIBA_MR_CC_Roster.pdf|'''Roster''']] | :[[Media:QIBA_MR_CC_Roster.pdf|'''Roster''']] | ||
Revision as of 16:39, 9 April 2018
- Chairs: Mark Rosen, MD, PhD (Co-Chair), Gudrun Zahlmann, PhD (Co-chair), Cathy Elsinger, PhD (Vice-chair)
- Secretary: Susan Stanfa (RSNA Staff)
- Roster
Scope
The MR Coordinating Committee coordinates Biomarker Committees based on MR.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the MR Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact the secretary for details.